Zachary Roberts, EVP of R&D at Allogene Therapeutics, Inc. (ALLO), sold 26,269 shares at $1.56 ($41K) on 2026-01-21, disclosed to the SEC on 2026-01-23.
Seasonal sale ($41k) by EVP of R&D — this insider has traded ALLO in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ALLO | SELL | 2025-01-23 | $48K | — | Filing → |